These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7661422)

  • 1. Emergency department vaccination of preschool-age children during a measles outbreak.
    Schlenker TL; Risk I; Harris H
    Ann Emerg Med; 1995 Sep; 26(3):320-3. PubMed ID: 7661422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 3. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measles, mumps and rubella vaccination status of school beginners in Munich].
    Markuzzi A; Schlipköter U; Weitkunat R; Meyer G
    Soz Praventivmed; 1997; 42(3):133-43. PubMed ID: 9334085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P
    Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine.
    Vitek CR; Aduddell M; Brinton MJ; Hoffman RE; Redd SC
    Pediatr Infect Dis J; 1999 Jul; 18(7):620-3. PubMed ID: 10440438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles vaccination in pediatric emergency departments during a measles outbreak.
    Lindegren ML; Atkinson WL; Farizo KM; Stehr-Green PA
    JAMA; 1993 Nov; 270(18):2185-9. PubMed ID: 8411600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].
    Pisón Garcés FJ; Galbe Sánchez-Ventura J; Arcauz Eguren P; Aguirre y Dabán C; Mengual Gil J; Larrad Mur L
    Aten Primaria; 1995 Mar; 15(4):235-7. PubMed ID: 7703334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the Centers for Disease Control and Prevention. Measles--United States, 1996, and the interruption of indigenous transmission.
    JAMA; 1997 May; 277(17):1345-6. PubMed ID: 9134928
    [No Abstract]   [Full Text] [Related]  

  • 11. Sentinel surveillance shows small decline in MMR coverage.
    Commun Dis Rep CDR Wkly; 1998 Sep; 8(36):317, 320. PubMed ID: 9782644
    [No Abstract]   [Full Text] [Related]  

  • 12. Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella.
    Böttiger M; Christenson B; Romanus V; Taranger J; Strandell A
    Br Med J (Clin Res Ed); 1987 Nov; 295(6608):1264-7. PubMed ID: 3120971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination.
    King GE; Markowitz LE; Heath J; Redd SC; Coleman S; Bellini WJ; Sievert A
    JAMA; 1996 Mar; 275(9):704-7. PubMed ID: 8594268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does a modified vaccination schedule protect better against measles?].
    van 't Spijker C; Rümke HC
    Ned Tijdschr Geneeskd; 1994 Nov; 138(48):2400-5. PubMed ID: 7990988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of two dose measles vaccination in a community setting.
    Phadke MA; Bhargava I; Dhaigude P; Bagade A; Biniwale MA; Kurlekar SU
    Indian Pediatr; 1998 Aug; 35(8):723-5. PubMed ID: 10216565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].
    Sáenz González MC; Núñez Mateos JC; Rodrigo Sánchez N; Martín Sánchez AM
    An Esp Pediatr; 1992 Apr; 36(4):293-7. PubMed ID: 1605414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.